Group of smiling people wearing protective head cap looking toward camera.

Neuromodulation

Our focus

Electronic implantable technologies and minimally invasive therapies that help patients manage debilitating chronic pain and neurological conditions such as movement disorders.

Erika’s story

At Boston Scientific, we’re dedicated to working closely with physicians and their patients to develop meaningful, industry-leading solutions that can improve the quality of life for millions worldwide. Our personalised pain solutions are designed to offer the broadest selection of evidence-based treatment options that address multiple pain targets and change patients' lives.

Delivering meaningful innovation

Advancing deep brain stimulation.

Because Parkinson’s disease is a progressive, neurodegenerative disorder, it’s critical to provide therapy that is designed to adapt to the patient’s evolving needs. The Vercise Genus™ Deep Brain Stimulation (DBS) System offers a broad rechargeable and non-rechargeable battery portfolio  with MRI conditionality.¹ The system is designed to treat the symptoms of movement disorders like Parkinson’s Disease, Dystonia essential tremor by delivering superior precision and targeted therapy. With our proprietary Multiple Independent Current Control (MICC) and the Vercise Cartesia™ Directional Leads, physicians can offer unmatched precision, flexibility and control. These unique therapy options combined with advanced image guided programming features are designed to make it easier than ever to manage patients' symptoms and adapt for continued symptom relief as the disease progresses. 

Individualised chronic pain care 

Each patient experiences pain differently, and pain can change over time. As a result, there is a need for technologies with multiple options that adapt with the changing needs of the patient. Our robust portfolio of therapies helps physicians deliver individualised care across a wide spectrum of chronic pain issues.

Personalised pain therapy

Our WaveWriter Alpha™ Spinal Cord Stimulator (SCS) Systems are designed to provide personalised, long-lasting pain relief. The portfolio of SCS devices is full-body MRI conditional², offering proprietary Fast Acting Sub-perception Therapy (FAST™) engineered to provide profound paresthesia-free pain relief to patients in minutes and our next-generation FAST AutoDose provides a proactive bolus multiple times a day. 

With rechargeable and non-rechargeable options, and the ability to provide multiple therapies in one device, patients and their physicians are given safe and effective options to find the therapy that works best for them.

Leading radiofrequency ablation

We offer radiofrequency ablation (RFA) systems used by physicians to treat patients with chronic pain. RFA is a versatile outpatient procedure that is often used prior to SCS in the treatment continuum for chronic pain and has more than a 50-year track record of providing relief for patients. 

check icon

96% of DBS patients would do the procedure again.3                               

check icon

38% of Europeans report their chronic pain is inadequately managed by medication alone.4                 

check icon

Patients with tremor experienced an average of 70% reduction of symptoms with DBS, depending on type and location.5 

Conditions we treat

  • Chronic Pain
  • Parkinson’s Disease
  • Essential Tremor
  • Dystonia 

1 in 5

adults in Europe are affected by chronic pain.⁶

1.2M

Parkinson’s is a movement disorder that affects more than 1.2 million people in Europe and over 10 million people worldwide.⁷

Solutions we offer

  • Rechargeable and Non-Rechargeable Spinal Cord Stimulator Systems
  • Radiofrequency Ablation Systems
  • Rechargeable and Non-Rechargeable Deep Brain Stimulation Systems 

Product spotlights

WaveWriter Alpha ™ Spinal Cord Stimulator Systems

The Vercise Genus™ Deep Brain Stimulation (DBS) System 

The Vercise Genus™ Deep Brain Stimulation (DBS) System is designed to make it easier than ever to manage patients' symptoms and adapt for continued relief as the disease progresses. 

Learn more about treatments for movement disorders
WaveWriter Alpha ™ Spinal Cord Stimulator Systems

WaveWriter Alpha™ Spinal Cord Stimulator (SCS) Systems

The WaveWriter Alpha SCS systems are the largest portfolio of full-body MRI conditional devices.² Boston Scientific SCS Systems can deliver multiple therapies simultaneously and have been clinically proven to provide greater relief from chronic pain.8  

Learn more about treatment options for chronic pain
Vercise Genus™ Deep Brain Stimulation (DBS) System

Radio Frequency (RF) - Versatile and reliable portfolio offering

The Boston Scientific Radio Frequency offering is one of the most versatile, intuitive and reliable RF portfolios for pain management that offers a wide range of standard and specialised products. 

The products are designed for ease of use, and the wide range of electrodes and cannula allows physicians to treat different patients and indications.

Boston Scientific G4™ generator is designed to give consistent results with a wide range of features in an easy-to-use interface. Ability to treat up to four sites at once with independently controlled electrode outputs using monopolar, bipolar, or pulsed RF. 

Learn more about treatment options for chronic pain

Sources

Results from clinical studies are not predictive of results in other studies. Results in other studies may vary.

¹ The Vercise Genus™ DBS System provides MRI access to full-body 1.5T scans when used under certain conditions as defined in the supplemental manual ImageReady™ MRI Guidelines for Boston Scientific DBS Systems.

² The WaveWriter Alpha™ and WaveWriter Alpha™ Prime Spinal Cord Stimulator Systems provide safe access to full-body 1.5T MRI scans when used with specific components and exposed to the MRI environment under the defined conditions in the ImageReady™ MRI Full Body Guidelines for WaveWriter Alpha™ and WaveWriter Alpha™ Prime Spinal Cord Stimulator Systems

³ Knoop et al. Bridging the gap in patient education for DBS surgery for Parkinson’s disease. Parkinson’s Disease. 2017. 2017: 1-6.

⁴ Societal Impact of Pain, 2016. Abstract & Background Booklet. https://www.sip-platform.eu/sip2016booklet. Last accessed: March 2017

⁵ Farris SM, Giroux, ML. (2013). DBS: A Patient Guide to Deep Brain Stimulation. 1st ed. CreateSpace Independent Publishing Platform; 2013.

⁶ Eur J Pain.2006 May;10(4):287-333. doi: 10.1016/j.ejpain.2005.06.009. Epub 2005 Aug 10.

⁷ WHO (World Health Organization). The global burden of disease: 2004 update. Genf, Schweiz: WHO; 2008.

⁸ North, James, MD. WHISPER: A Multicenter, Prospective Randomized Controlled Trial Evaluating Subperception SCS at ≤ 1.2 kHz. Presentation at North American Neuromodulation Society (NANS), Las Vegas, NV, January 11-14, 2018. (N=70) 

 

This material is for informational purposes only and not meant for medical diagnosis. This information does not constitute medical or legal advice, and Boston Scientific makes no representation regarding the medical benefits included in this information. Boston Scientific strongly recommends that you consult with your physician on all matters pertaining to your health.

 

CAUTION: The law restricts these devices to sale by or on the order of a physician. Indications, contraindications, warnings, and instructions for use can be found in the product labelling supplied with each device or at www.IFU-BSCI.com. Products shown for INFORMATION purposes only and may not be approved or for sale in certain countries. This material not intended for use in France. 2024 Copyright © Boston Scientific Corporation or its affiliates. All rights reserved.

All trademarks are the property of their respective owners.